Obesity 101 - Dr. Michele Yuen

Unusual infections in diabetes:case studies - Dr. Bharat Purandare

Insulin autoantibody syndrome: varied clinical presentations - Dr. Arun Menon

Health promotion and Prevention and management of Non-communicable diseases - Dr. Monika Arora

Precision medicine: hype or hope - Dr. Arundhati Dasgupta

Language matters - examples of conversations in diabetes care - Dr. Chitra Selvan

In PCOS, metformin should alwaysbe the first line pharmacotherapy (No) - Dr. Lakshmi Nagendra

In PCOS, metformin should alwaysbe the first line pharmacotherapy (yes) - Dr. Sarah Alam

A clinician’s journey towards basic diabetes research: a personal perspective - Dr. Suresh Shinde

Getting basics right in improving outcomes for people with T2DM - Dr. Kamlesh Khunti

Diabetic foot management in clinical practice: an 2021 update - Dr. John Doupis

KDIGO diabetes and CKD guidelines

Two decades of gla-100-reflections from the pivotal clinical trials and real world studies.

Tenets of gen 2.0 basal addressing variability and time in range - Dr. K. K. Gangopadhyay

Role of gen 2.0 basal in optimizing glycemic levels in hospitalized patients - Dr. Debmalya Sanyal

Islet auto transplantation: the science simplified - Dr. Chirag Desai

Exocrine pancreatic dysfunction in diabetes - Dr. Suresh Chari

Islet auto transplantation: clinical case based perspective - Dr. Chirag Desai

Newer drugs for diabetes management - Dr. Ananda basu

Indian perspective on the diagnosis of type 1 diabetes - Dr. Suganthi Kumaran

Glycemic and ketone monitoring in type 1 diabetes - Dr. Nupur Lalwani & Dr. Nikita Sarkar

Insulin pump therapy in type 1 diabetes - Dr. Jothydev Kesavdev

Physical activity in type 1 diabetes - Dr. Nupur Lalwani

Dental health, diabetes and systemic inflammation - clinical insights - Dr. Poonam Jadhav

Type 1 diabetes always requires CSII - Dr. Om Lakhani

Management of diabetic ketoacidosis and hyperosmolar hyperglycemic state - Dr. Pankaj Shah

Using CGM with AGP analytics in clinical practice - Dr. Roger Mazze

Testing for non-pancreatic autoimmunity in type 1 diabetes: Case Study - Dr. Vaman Khadilkar

Understanding HbA1C testing - Dr. Ranjit Unnikrishnan

Designing a complication screening protocol - Dr. Vedavati Purandare

The 2022 LADA update - Dr. C. B. Sanjeevi

Foreign bodies in diabetic foot: three case studies - Dr. Ravindra Panse

Case studies in diabetic retinopathy - Dr. Savita Bhat

Non-proteinuric diabetic kidney disease - Dr. Charan Bale

Diabetic foot ulcer: case studies - Dr. Amrish Bidaye

Hypothyroidism and women’s health: clinical perspective - Dr. Beena Bansal

Managing hypertension with Diabetes: ADVANCing beyond arbitrary BP values

Managing very difficult cases of diabetes: clinical perspectives - Dr. Sanjay Gandh

GDM, subsequent glucose intolerance and coronary calcium scores: a clinical perspective

Automating insulin therapy to improve patient care - Dr. Ohad Cohen

Paradigm Shift in T2DM management -Focus on Cardio-Renal Protection - Dr. Shailaja Kale

Subclinical COVID-19 and new on set type 1 diabetes: a case series - Dr. Sanket Pendsey

Outpatient management of diabetes during COVID: Case studies - Dr. Nanditha Arun

Clinical implications of glycemicvariability and TOPTIR study - Dr. Suhas Erande

Non-insulin antidiabetic agents inpatients with type 2 diabetes andCOVID – a critical appraisal

Paediatric diabetic kidney disease – case studies - Dr. Manisha Sahay

Clusters that predictdiabetes treatment - Dr. R M Anjana

Imaging in diabetic retinopathy: what is new - Dr. Muna Bhende

Basal insulin supported oralcombination therapy in T2DMcasebased approach - Dr. Varsha Jagtap

Bone health and diabetes - Dr. Ambrish Mithal

Diabetic foot :a global view - Dr. Vijay Vishwanathan

How to develop your own in-hospitalinsulin infusion protocol - Dr. Ashutosh Pakal

Organ protective effects of metformin in diabetes and beyond - Dr. Juliana Chan

Real world evidence on T2Dmanagement - insights from JADE registry - Dr Uday Phadke

Vitamin D deficiency: a 2022 update - Dr. Sanjay Bhadada

Non-diabetic hypoglycaemia: case studies - Dr. Pankaj Shah

Breaking barriers of insulin initiation intune with indian patient needs - Dr. Gagan Priya

Positioning TiR in diabetesmanagement: role of newerbasal insulins - Dr. Shehla Shaikh

Intricacies of IP hyperglycemia management - Dr. Chitra Selvan

Non-surgical Management of Obesity - Dr. Michele Yuen

Obesity, Type 2 diabetes and unusual comorbidities - Dr Meenakshi Kalyan

Gliptin, gliflozin, synergy - Dr. Ashish Dengra

What is obesity? - Dr. Neeta Deshpande

The clinical barophenotype concept - Dr. Nitin Kapoor

Endocrine causes of obesity - Dr. Rakesh Sahay

Childhood obesity – the rationalefor early intervention - Dr. Annika Janson

Nutritional approaches to obesity - Dr. Sheryl Salis

Exercises is not about walking30 minutes/day - Dr. Malhar Ganla

Obesity management invegetarians – case studies - Dr. Geeta Dharmatti

Clinical work up for patientsundergoing bariatric surgery - Dr Deep Dutta

The big 3: Semaglutide,Tirzepatide and Cagrisema - Dr. Mohan Shenoy

Endoscopy, gastric pill andother interventions - Dr. Satish Pattanshetti

Bariatric surgery – What is new? - Dr. Shashank Shah

A basic algorithm for obesity management - Dr. Nitin Kapoor

Oral semaglutide: The GAME CHANGER in the armamentarium of diabetes management - Dr. V Mohan

Spectrum of benefits of oralsemaglutide beyond glycemic control - Dr. Sanjay Kalra

Crucial role of oral semaglutide in Indian clinical settings - Dr. Samit Ghosal

Patient-centric management with oral semaglutide: A case based discussion - Dr. Rajiv Kovil

Calorie counting – a pictorial atlas - Dr. Rutuja Mahajan

Carbs counting – anillustrative perspective - Dr. Parita Gajjar

Timely intervention in T2DM: practical considerations in achieving early and sustained glycemic ctrl

Can a broad range of patients withT2DM benefit from the simplicity of linagliptin-Dr. Ambrish Mithal

Empowering organ protection as standard of care in T2DM current perspective for sglt2 inhibition

Childhood obesity and type 2 diabetes - Dr. Annika Janson

Vildagliptin 100 mg – role inclinical practice - Dr. Manoj Chadha

Once weekly GLP1rs: new insights from REWIND trial - Dr. Manoj Chawla

Empagliflozin therapy across the heart failure spectrum - Dr. J C Mohan

Next generation pump technology - Dr. Jothydev Kesavadev

When is technology too much? - Dr. Tejal Lathia

Digital therapeutics –the diabetes story - Dr. Arbinder Singal

Kidney protection! A reality with Dapagliflozin - Dr. Sunil M Jain

Is glucose control good enough for diabetes patients? - Dr. Altamash Shaik

Practical tips and addressing clinical inertia with SGLT2i - Dr. Awadhesh Kumar Singh

Current management of diabetes neuropathy in 2022: Treat Feet Early! - Dr. Vijay Negalur

Subclinical hypothyroidism: case studies that illustrate management - Dr. Vaishali Deshmukh

Evolution of basal insulin optimization approaches over Two decades in India - Dr. Krishna Seshadri

What is Type 3 c diabetes? - Dr. Suresh Chari

Understanding glucagon Pathophysiology in diabetes - bedside to bench - Dr. Ananda Basu

Early detection and prevention of complications in T2DM - Dr. Hemraj Chandalia

Challenges in coronary intervention in diabetic patients - case studies - Dr. Michael Chan

PCOS and Diabetes: case studies that illustrates the association - Dr. Mathew John

Adverse effects of incorrect insulin administration - Dr. Manoj Chawla

Improving patient care through diabetes care app/ digital technology - Dr Sanjay Kalra

Building a high quality diabetes care team - Dr. Sunil M Jain

The doctor as an entrepreneur : how I think - Dr. Santosh Ramakrishnan

Getting ready to start your endocrine/diabetes centre? What the book won’t tell you

Strategic use of social media: advice from a doctor - Dr. Karthik Balachandran

The power of networking explained - Dr Sanjay Kalra

Applying technology indaily diabetology - Dr. Ameya Joshi

Making excellence a habit - Dr. V Mohan

Influenza vaccination in diabetes: a 2022 update - Dr. Agam Vora

Sulfonylurea in 2022: still standing tall - Dr. Karthik Balachandran

Management of hypertriglyceridemia: What works? What may work? - Dr. Vinaya Simha

CGM, glucose exposures and variabilities: are A1c and TIR sufficient? - Dr. Roger Mazze

Nobel prize in medicine - Dr. C B Sanjeevi

Obesity medicine and type 2 diabetes remission – a primary care perspective - Dr. Manjul Patwardhan

Exercise advice is not about walking 5 days a week! - Dr. Nikita Morwal

Keto diets, intermittent fasting and type 2 diabetes - Dr. Rucha Mehta

Meal replacement in diabetes - Dr. Sheryl Salis

Vegetarian and vegan protein-rich diets in diabetes reversal - Dr. Geeta Dharmatti

Case studies on de-intensifying diabetes during a reversal program - Dr. V K Abichandani

Impact of ReTUNE upon understanding of the aetiology of T2DM - Dr. Roy Taylor

How to define diabetes remission? - Dr. Om Lakhani

Practical management of T2DM in non-obese people - insights from ReTUNE - Dr. Roy Taylor

Metabolodiuretic promiseof dapaglifozin - Dr. Shailaja Kale

Diabetes is equivalent to heart failure - logic of early intervention with dapaglifozin

Why Dapaglifozin + DPPIVi make a great combination? - Dr. Sanjeev Shah

Diabetes prevention – today and tomorrow - Dr. A Ramachandran

Dapagliflozin use in high risk cardiovascular patients : what does the evidence foretell?

Meaningful glucose monitoring - Dr. Sachin Chittawar

Welcome & introduction - Dr. Rakesh Sahay

Diabesity and mitochondrial dysfunction - Dr. Tiny Nair

Mitochondria… new therapeutic target for CV risk modulation - Dr. Subhankar Chowdhury

Management of indian diabetic dyslipidemia- meeting goals, saving lives - Dr. Om Lakhani

Diabetes and sympathetic overactivity-silent precursor to CAD - Dr. Varsha Jagtap

High risk CAD-long termstrategy with ticagrelor - Dr. Rajiv Sethi

Diabetes and cancer –what is the missing link? - Dr. Juliana Chan

Perioperative diabetes management - Dr. Vinaya Simha

Case studies for diabetes and COVID - Dr. J Muthukrishnan

Glycemic variability - Dr. Uday Phadke

Managing Menopause Matters - Dr. Girija Wagh

Premature/ early menopause & metabolic syndrome in endocrine mirror - Dr. Tejal Lathia

Newer HRTs: A hope for millionsof indian women - Dr. Krishna Seshadri

Universal solution for diabetes management across various baseline HbA1c, background therapies and co-morbidities - Dr. Girish Parmar

Charcot foot: clinical perspectiveand case studies - Dr. Ashu Rastogi

Role of dapagliflozin in control of hypertension in different subsets - Dr. Tiny Nair

Evolving evidence withnewer DPP4I : evogliptin - Dr. Awadhesh Kumar Singh

Relevance of hydroxychloroquine in the management of type 2 diabetes - Dr. Manoj Chadha

Time in Range, A1C and the role of A1C in CGM - Dr. Jothydev Kesavdev

How are modern-day connected SMBG systems changing patient care? - Dr. Piya Ballani

Successful interpretation of SMBG in clinical practice – some case studies - Dr. Sujoy Ghosh

Management of dyslipidaemia in patients with diabetes and CAD - Case based perspectives

Initiating insulin therapy withbasal insulin: a 2022 update - Dr. Banshi Saboo

Anemia in diabetes:a clinical perspective - Dr. Mangesh Tiwaskar

Clinical applications of remogliflozin based combinations in T2DM management.

Diabetes in the elderly:clinical considerations - Dr. Sanjay Agarwal

Nutritional approaches to type 1diabetes: understanding correction factors and the I:C ratio